Med. praxi. 2019;16(1):23-26 | DOI: 10.36290/med.2019.004
Metabolic syndrome is defined by the presence of several factors that share a common pathophysiological basis. The presence of metabolic syndrome is associated with a high risk of fatal cardiovascular and cerebrovascular events. The prevalence of metabolic syndrome is high. The management of metabolic syndrome is always comprehensive. The treatment of arterial hypertension as part of metabolic syndrome has its specific features. Metabolically neutral and metabolically positive drugs are preferred, particularly those of the renin-angiotensin system inhibitor group. A combination with statins is beneficial for their potential to reduce the risk of cardiovascular events. A modern treatment of hypertension and metabolic syndrome utilizes the option of fixed drug combinations that increase patient adherence to therapy.
Published: February 25, 2019 Show citation